Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in Advanced Solid Tumors and Lymphomas
NCT00389077Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Jan 2005
- Primary completion
- Jul 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of perifosine in solid tumor, lymphoma, sponsored by COSCIENS Biopharma Inc.. Started Jan 2005; status: completed.
02
Drugs
perifosine
03
Conditions
solid tumorlymphoma
Beyond the preview
Go deeper on NCT00389077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389077.